106 related articles for article (PubMed ID: 3556394)
21. Phencyclidine-induced stereotyped behaviors after injection of morphine and N-allylnormetazocine (SKF 10,047) in rats.
Nabeshima T; Hiramatsu M; Kameyama T
Pharmacol Biochem Behav; 1986 Jun; 24(6):1629-34. PubMed ID: 3016758
[TBL] [Abstract][Full Text] [Related]
22. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
Green AR; DeSouza RJ; Davies EM; Cross AJ
Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
[TBL] [Abstract][Full Text] [Related]
23. Repeated cocaine administration does not affect 5-HT receptor subtypes (5-HT1A, 5-HT2) in several rat brain regions.
Javaid JI; Sahni SK; Pandey SC; Davis JM
Eur J Pharmacol; 1993 Jul; 238(2-3):425-9. PubMed ID: 8405113
[TBL] [Abstract][Full Text] [Related]
24. Effects of two 5-hydroxytryptamine agonists on head-weaving behaviour in streptozotocin-diabetic mice.
Fujii E; Nomoto T; Muraki T
Diabetologia; 1991 Aug; 34(8):537-41. PubMed ID: 1834508
[TBL] [Abstract][Full Text] [Related]
25. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
[TBL] [Abstract][Full Text] [Related]
26. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
Backus LI; Sharp T; Grahame-Smith DG
Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
[TBL] [Abstract][Full Text] [Related]
27. 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice.
Goodwin GM; Green AR; Johnson P
Br J Pharmacol; 1984 Sep; 83(1):235-42. PubMed ID: 6237705
[TBL] [Abstract][Full Text] [Related]
28. Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin.
Krebs-Thomson K; Lehmann-Masten V; Naiem S; Paulus MP; Geyer MA
Eur J Pharmacol; 1998 Feb; 343(2-3):135-43. PubMed ID: 9570460
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin.
Hiramatsu M; Nabeshima T; Fukaya H; Furukawa H; Kameyama T
Eur J Pharmacol; 1986 Jan; 120(1):69-74. PubMed ID: 3456306
[TBL] [Abstract][Full Text] [Related]
30. Effect of naftidrofuryl oxalate on 5-HT2 receptors in mouse brain: evaluation based on quantitative autoradiography and head-twitch response.
Nabeshima T; Hiramatsu M; Niwa K; Fuji K; Kameyama T
Eur J Pharmacol; 1992 Nov; 223(2-3):109-15. PubMed ID: 1478263
[TBL] [Abstract][Full Text] [Related]
31. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219
[TBL] [Abstract][Full Text] [Related]
32. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
Fischette CT; Nock B; Renner K
Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the serotonergic neuronal system in phencyclidine-induced place aversion in rats.
Kitaichi K; Noda Y; Miyamoto Y; Numaguchi A; Osawa H; Hasegawa T; Furukawa H; Nabeshima T
Behav Brain Res; 1999 Aug; 103(1):105-11. PubMed ID: 10475170
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological analysis of the variation in behavioural responses to tryptamine in five strains of mice.
Yamada J; Sugimoto Y; Horisaka K
Eur J Pharmacol; 1987 Aug; 140(3):323-30. PubMed ID: 3653248
[TBL] [Abstract][Full Text] [Related]
35. Influence of lipid peroxidation on [3H]ketanserin binding to 5-HT2 prefrontal cortex receptors.
Rego AC; Oliveira CR
Neurochem Int; 1995 Dec; 27(6):489-96. PubMed ID: 8574178
[TBL] [Abstract][Full Text] [Related]
36. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
Bischoff S; Heinrich M; Sonntag JM; Krauss J
Eur J Pharmacol; 1986 Oct; 129(3):367-70. PubMed ID: 3536532
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of phencyclidine-induced dopamine-dependent behaviors in rats after pretreatments with serotonin-depletors.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 May; 9(5):479-89. PubMed ID: 2945001
[TBL] [Abstract][Full Text] [Related]
38. Serotonin receptor sensitivity after acute and chronic treatment with mianserin.
Blackshear MA; Sanders-Bush E
J Pharmacol Exp Ther; 1982 May; 221(2):303-8. PubMed ID: 7077527
[TBL] [Abstract][Full Text] [Related]
39. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
40. Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats.
Nabeshima T; Yamada K; Yamaguchi K; Hiramatsu M; Furukawa H; Kameyama T
Eur J Pharmacol; 1983 Aug; 91(4):455-62. PubMed ID: 6684578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
